CytoDyn CEO claims Covid-19 drug success, but details suggest it failed

CytoDyn CEO claims Covid-19 drug success, but details suggest it failed

STAT Plus: CytoDyn CEO claims Covid-19 drug success while describing data suggesting study failure

By ADAM FEUERSTEIN

CytoDyn's CEO claimed success on an investor call — but his description of the data suggests the study didn't meet its primary goal.

READ MORE